Members of this family are cluster of differentiation 80 (CD80 or B7-1), CD86 (B7-2), CD274 (B7-H1 or PD-L1), PDCD1LG2 (PD-L2), ICOSLG (B7-H2), CD276 (B7-H3), VTCN1 (B7-H4), VSIR (B7-H5), NCR3LG1 (B7-H6), HHLA2 (B7-H7) and ILDR2 ( 131 I Omburtamab for neuroblastoma, Enoblituzumab for prostate cancer, and GSK5764227 (HS-20093) for small-cell lung cancer, highlights the progress in this area
DOI: Published online: January 9, 2024 Division of Endocrinology, Department of Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands Corresponding author: Aart J
In October 2025, Severe Gastrointestinal Adverse Reactions was added to the WARNING AND PRECAUTIONS section of the label
275,279 The results of others studies support this hypothesis, since high NAMPT protein and mRNA levels were observed when muscle cells were treated with the AMPK activator AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide)
Results are expressed as the mean SD
A prescription is required and results may vary
